Survival, Mortality, & Causes of Death

Survival, Mortality, & Causes of Death

EIGHT Survival, Mortality, 8sd Causes o f Death He was excellent indeed, madam: the king very lately spoke of him admiringly and mourningly: he was s...

18MB Sizes 1 Downloads 97 Views

EIGHT Survival, Mortality, 8sd Causes o f Death

He was excellent indeed, madam: the king very lately spoke of him admiringly and mourningly: he was skillful enough to have lived still, if knowledge could be set up against mortality. William Shakespeare, All's Well That Ends Well

American Journal of Kidney Diseases, Vol 36, No 6, Suppl 2 (December), 2000: pp S127-S142

Si28

· 2000

ATLAS

OF

ESRD

IN

THE

UNITED

STATES

Since 1988, first-year death rates for all incident

The association over time between death rates

dialysis patients have fallen 38.5%, with the great­

and hematocrit levels varies by diabetic status (figs

est decrease (63.7%) occurring in patients on

8.16-18). While the death rates decline with

peritoneal dialysis (fig 8.1). Death rates for trans­

higher hematocrits in both diabetics and non-

plant patients, consistently much lower than those

diabetics, they tend to flatten out as hematocrit

for patients on dialysis, fell 93% in the same pe­

levels reach 33%. The consistently lower death

riod. Rates have decreased for all age groups of

rates at higher hematocrit levels support the

both hemodialysis and peritoneal dialysis pa­

DOQI target range of 33-36%.

tients, with younger patients consistently having lower death rates than their older counterparts.

In figures 8.1-15 and 8.19-21 data are adjusted

Declines infirst-yeardeath rates have been com­

for age, race, gender, and/or diabetic status; they

parable for male and female patients on both mo­

are not, however, adjusted for other clinical fac­

dalities—approximately 48% for hemodialysis,

tors, such as comorbidity and disease severity,

and 64% for peritoneal dialysis (figs 8.4-5).

which may influence the death rates. Adjustments for these latter factors, however, are made in fig­

In terms of race, first-year death rates have de­

ures 8.16-18, which show associations between

clined most in Asian patients, 58.3% for hemo­

hematocrit and mortality.

dialysis and 71.9% for peritoneal dialysis. The rate for white hemodialysis patients shows a slightly

Figures 8.22-32 present death rates for prevalent

higher decline (48%) than that for blacks and

patient cohorts. Since these cohorts consist of

Native Americans, 43.1% and 38.8% respectively.

patients with varying amounts of time on ESRD

This trend is somewhat different for peritoneal

and varying modality histories, and are affected

patients, however, with the decrease for blacks

as well by the selection bias related to transplan­

being 64% compared to 61.7% in whites and

tation, the graphs should be interpreted with cau­

53.9% in Native Americans (figs 8.6-7).

tion.

Death rates for diabetics, hypertensive patients,

Overall, the fall in death rates has been concur­

and patients with other renal diseases have be­

rent with improvements in dialysis therapy and

gun to converge for hemodialysis patients, but

anemia treatment, and with changes in mem­

this is not the case for the peritoneal dialysis popu­

brane use from cuprophane to synthetic mem­

lation, in which diabetics continue to have the

branes (see Chapter Ten).

All data underlying the highest rates of death (figs 8.8-9). Differences by modality are also apparent in first, second-, and figures in this chapter, third-to-fifth year death rates (fig 8.10). These patterns suggest that the two dialysis modalities as well as additional related are not proportional to one another over time, a fact that complicates comparisons between them. data, may be viewed & Five-year survival curves show that female padownloaded at

tients live longer than males across most age groups, races, primary diagnoses, and modalities

www.usrds.org.

(figs 8.11-14).

Included in this chapter ♦ Graphs of first-year death rates by modality, age group.gender, race.and primary diagnosis ♦ Five-year survival curves by gendecage group, race,primary di­ agnosis, and modality ♦ Maps of first-,second-,third-,and fourth-year overall death rates, as well as maps of all-cause, infectious, and cardiac death rates ♦ Graphs of the association between mortality and hematocrit ♦ Graphs of cause-specific death rates by modality, race.and age group

CHAPTER

8 ·

SURVIVAL,

30 -

20 ■

10 -

All dialysis (29.9, -38.5%) Hemodialysis (28.1,-48%) Peritoneal dialysis (27.8, -63.7%) Transplant (2.9,-93%)

40 ■

a

30 ■

DEATH

· S129

Reference population: the aver­ age 1997 incident patient in each modality.

Figure 8.2 First-year death rates by age group incident hemodialysis patients, adjusted for gender, race, & primary diagnosis of diabetes

45

35

OF

The number of deaths per 100 patient years in 1988, and the percent change in values be­ tween 1988and 1997,are shown in the legend.

25

15 ■

& CAUSES

Figure 8.1 First-year death rates by modality incident patients, adjusted for age, gender, race, & primary diagnosis of diabetes

35

S

MORTALITY,

■ 0-19(9.7,-71.1 20-44(16.7,-63.1 ■ 45-64 (24.6, -50.4%) ■ 65+ (42.7, -32.3%)

The number of deaths per 100 patient years in 1988, and the percent change in values be­ tween 1988 and 1997,are shown in the legend. Reference population: the aver­ age 1997 incident hemodialysis patient in each age group.

Figure 8.3 First-year death rates by age group incident peritoneal dialysis patients, adjusted for gender, race, & primary diagnosis of diabetes The number of deaths per 100 patient years in 1988, and the percent change in values be­ tween 1988 and 1997,are shown in the legend. Reference population: the aver­ age 1997 incident peritoneal di­ alysis patient in each age group.

Si30

■ 2000

ATLAS

OF

ESRD

IN

THE UNITED

STATES

Figure 8.4 First-year death rates by gender incident hemodialysis patients, adjusted for age, race, & primary diagnosis of diabetes The number of deaths per 100 patient years in 1988, and the percent change in values be­ tween 1988and 1997,are shown in the legend.

30 ω 25

Reference population: the aver­ age 1997 incident hemodialysis patient of each gender.

Male (30.2, -49.7%) Female (25.9, -46.3%)

1990

1991

1992

1993

1994

1995

1996

1993

1994

1995

1996

1997

1996

1997

Figure 8.5 First-year death rates by gender incident peritoneal dialysis patients, adjusted for age, race, & primary diagnosis of diabetes The number of deaths per 100 patient years in 1988, and the percent change in values be­ tween 1988and 1997,are shown in the legend.

30 ω 25

Reference population: the aver­ age 1997 incident peritoneal di­ alysis patient of each gender.

20

Figure 8.6 First-year death rates by race incident hemodialysis patients, adjusted for age, gender, & primary diagnosis of diabetes The number of deaths per 100 patient years in 1988, and the percent change in values be­ tween 1988 and 1997,are shown in the legend. Reference population: the aver­ age 1997 incident hemodialysis patient of each race.

40 -, 35 30' ω 25 20

Q

10 5

Black (19.5,-43.1 Native American (17, -38.8%) Asian (22.3, -58.3%)

0 1989

1990

CHAPTER

8 ·

SURVIVAL,

MORTALITY,

& CAUSES

OF

DEATH

· S131

Figure 8.7 First-year death rates by race incident peritoneal dialysis patients, adjusted for age, gender, & primary diagnosis of diabetes The number of deaths per 100 patient years in 1988, and the percent change in values be­ tween 1988 and 1997,are shown in the legend.

30 ω 25

Reference population: the aver­ age 1997 incident peritoneal di­ alysis patient of each race.

20 15 10 -

White (31.3,-61.7%) Black (20.3, -64%) Native American (14.3, -53. Asian (15.3,-71.9%) 1990

1991

1995

1992

1996

1997

Figure 8.8 First-year death rates by primary diagnosis incident hemodialysis patients, adjusted for age, gender, & race The number of deaths per 100 patient years in 1988, and the percent change in values be­ tween 1988and 1997,areshown in the legend.

25

Reference population: the aver­ age 1997 incident hemodialysis patient with each primary diag­ nosis.

20 ■ 15 10 -

■ Diabetes (32.8, -50.3%) ■ Hypertension (26.7, -44.8%) ■ Glomerulonephritis (17.7, -59.3%) Other (25.0,-39.2%) 1990

1991

1993

1994

1995

1996

1997

Figure 8.9 First-year death rates by primary diagnosis incident peritoneal dialysis patients, adjusted for age, gender, & race

Diabetes (35.7, -53.5%) Hypertension (29.5, -66.8 Glomerulonephritis (16.6, -78.3%) Other (21.3,-624

35 £ 30

The number of deaths per 100 patient years in 1988, and the percent change in values be­ tween 1988and 1997,are shown in the legend.

25

Reference population: the aver­ age 1997 incident peritoneal di­ alysis patient with each primary diagnosis.

20 ■

10 ■

1989

1990

1995

1996

1997

Si32

· 2000

ATLAS

Figure 8.10 First-, second-, &third-to-fifth year annual death rates incident patients, adjusted for age, gender, race, & primary diagnosis of diabetes The number of deaths per 100 patient years in 1988, and the percent change in values be­ tween 1988 and the last year shown for each death rate, are shown in the legends. Reference population: the aver­ age 1997 incident patient on each modality.

OF

ESRD

IN

THE UNITED

Peritoneal dialysis

Hemodialysis

30

STATES

r 20

-£ 10

• First-year (27.8,-63.7%)

First-year (28.1,-48%) Second-year (25.8, -36%) ■ Third-to-fifth year (26, -8.8%)

• Second-year (27.8, -45.7%) ■ Third-to-fifth year (28.1,-18.19

_l_ _l_ 1990 1991 1992 1993 1994 1995 1996 1997 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997

Table 8.1 Expected remaining lifetimes (years) by race & gender prevalent patients, 1998 Reference: Table H.3, H.4, H.12, andH.13.

Figure 8.11 Five-year survival curves by age group & gender incident dialysis patients, 1993, adjusted for race & primary diagnosis of diabetes

Age 0-14 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75-79 80-84 85 +

Dialysis White M 19.5 16.4 13.6 11.5 9.7 8.3 7.2 6.2 5.3 4.5 3.7 3.0 2.7 2.3 2.0 1.6

100 -,

Black M F| 18.7 23.1 15.8 20.8 17.6 13.0 11.0 15.1 12.9 9.3 11.1 8.1 7.1 9.6 6.3 8.3 5.2 7.0 4.6 5.9 3.9 5.0 3.2 4.0 3.4 2.7 2.4 2.9 2.4 2.0 1.9 1.6

I Nat. American j Asian M F M F 30.4 27.1 26.0 22.2 24.1 21.2 20.6 19.9 20.5 17.9 17.3 16.8 14.7 17.6 15.3 14.4 12.4 15.0 13.0 12.3 12.9 11.3 10.6 10.7 11.0 9.7 9.1 9.3 7.7 9.3 8.3 8.0 7.7 7.0 6.5 6.8 6.6 6.0 5.4 5.9 5.4 4.9 4.5 5.0 4.3 4.0 3.6 4.1 3.6 3.4 3.0 3.5 2.9 2.8 2.5 2.9 2.4 2.4 2.4 2.0 1.9 1.9 1.5 1.9

Transplant Black White F M M F 47.4 45.9 30.9 47.5 24.4 35.4 35.6 35.1 32.3 31.6 20.9 31.9 28.1 27.4 18.0 27.6 24.4 23.6 15.4 23.7 20.9 20.0 13.3 20.1 17.4 16.4 16.7 11.5 13.4 14.3 13.7 9.8 10.4 11.1 10.7 8.2 7.5 8.0 7.7 7.0 4.2 4.4 4.2 5.7 4.6 3.9 3.2 2.7 2.1

Male

Female

Reference population: the aver­ age 1997 incident dialysis pa­ tient of the same gender and age group. 60

40

20

5

1

Years of ESRD

F 44.2 34.0 30.9 26.8 23.1 19.7 16.4 13.4 10.5 7.6 4.3

Nat. American Asian M F M 52.3 50.1 52.3 39.4 37.3 39.1 35.2 33.3 34.9 30.6 28.9 30.3 26.4 24.8 26.0 20.9 21.9 22.3 18.3 17.2 18.0 14.4 14.8 13.9 10.7 11.3 11.0 7.9 7.6 7.8 4.3 4.2 4.3

F 54.5 41.5 37.3 32.7 28.3 24.1 20.0 16.1 12.3 8.6 4.6

CHAPTER

100

8 ·

SURVIVAL,

MORTALITY,

Male

Female

& CAUSES

OF

DEATH

· Sl 3 3

Figure 8.12 Five-year survival by race & gender incident dialysis patients, 1993, adjusted for age & primary diagnosis of diabetes Reference population: the aver­ age 1997 incident dialysis pa­ tient of the same gender and race.

40 ■

White Black ■ Native American ■ Asian

20 ■

1

5 Years of ESRD

100

Male

Female

Figure 8.13 Five-year survival by primary diagnosis & gender incident dialysis patients, 1993, adjusted for age & race Reference population: the aver­ age 1997 incident dialysis pa­ tient of the same gender and primary diagnosis.

60 ■

40 Diabetes Hypertension Glomerulonephritis Other

20 ■

Years of ESRD

100

Male

Female

Figure 8.14 Five-year survival by modality & gender incident dialysis patients, 1993, adjusted for age, race, & primary diagnosis of diabetes Reference population: the aver­ age 1997 incident dialysis pa­ tient of the same gender and modality.

60 ■

40 -

20

Hemodialysis Peritoneal dialysis

5

1 Years of ESRD

Si34

■ 2000

ATLAS

OF

ESRD

IN

THE UNITED

STATES

First-year death rates,1993-1995 combined

First-year death rates, 1990-1992 combined

■ ■ ■ •

28.0 + 25.1 to 28.0 23.6 to 25.1 21.7 to 23.6 below 21.7

Second-year death rates, 1990-1992 combined

■ 28.0 + ■ 55.1 to 28.0 4 23.6 to 25.1 21.7 to 23.6 uelow 21.7

Second-year death rates, 1993-1995 combined

■ ■ % li

283 + 26.0 to 28.3 243 to 26.0 20.8 to 243 below 20B

Third-year death rates, 1990-1992 combined

.3 + ■ 26.0 to 283 «* 24.3 to 26.0 20.8 to 243 below 20.8 Third-year death rates,1993-1995 combined

29.3 + 262 to 293 B 25.2 to 262 . 22.9 to 252 below 22.9

Fourth-year death rates, 1990-1992 combined

_-J_

"

•\ r

^

■ 29.3 + ■ 26.2 to 293 * 25.2 to 262 22.9 to 252 below 22.9

Fourth-year death rates,1993-1995 combined

31.0 + 28.5 to 31.0 B 25.7 to 28.5 * 23.6 to 25.7 below 23.6

Figure 8.15 First-, second-, third-, & fourth-year death rates per 100 patient years at risky incident dialysis patients, by state, adjusted for age, gender, race, & primary diagnosis of diabetes Reference population:the average 1997 incident dialysis patient.

\.

31.0 + 28.5 to 31.0 ■ 25.7 to 285 23.6 to 25.7 below 23.6

C H A P T E R

8

·

SURVIVAL,

M O R T A L I T Y ,

&

CAUSES

OF

2nd year 3rd year Overall

27-<30

30-<33

33-<36

36+

Diabetic

<27

27-<30

30-<33

33-<36

36+

Figure 8.17 Associations between mortality & hematocrit level by years of follow-up

Non-diabetic

incident hemodialysispatients, 1993-1996 combined, adjusted for patient characteristics, comorbidity, & severity of disease in the entry period

1st year 2nd year 3rd year Overall

<27

27-<30

30-<33

33-<36

36+

Diabetic

<27

27-<30

30-<33

33-<36

36+

Figure 8.18 Associations between mortality & hematocrit level by years of follow-up

Non-diabetic

incident peritoneal dialysis patients, 1993-1996 combined, adjusted for patient characteris­ tics, comorbidity, & severity of disease in the entry period

1st year 2nd year 3rd year Overall

<27

27-<30

30-<33

33-<36

36+

lulu«! <27

S135

incident dialysis patients, 19931996 combined, adjusted for patient characteristics. comorbtdity, & severity of disease in the entry period

1st year

<27

·

Figure 8.16 Associations between mortality & hematocrit level by years of follow-up

Non-diabetic

Diabetic

DEATH

27-<30

30-<33

33-<36

36+

Si36

·

2000

ATLAS

OF

ESRD

IN

THE

UNITED

STATES

Hemodialysis, first-year death rates, 1990-1992 combined

Hemodialysis,first-year death rates, 1993-1995 combined

Hemodialysis, second-year death rates, 1990-1992 combined

Hemodialysis, second-year death rates, 1993-1995 combined

Peritoneal dialysis,first-year death rates, 1990-1992 combined

Peritoneal dialysis, first-year death rates, 1993-1995 combined

Peritoneal dialysis, second-year death rates, 1990-1992 combined

Peritoneal dialysis, second-year death rates, 1993-1995 combined

Figure 8.19 All-cause death rates

per 100 patient years at risk, incident patients, by state, adjusted for age, gender, race, & diabetic status While all-cause death rates have clearly decreased since 1992, an analysis that includes more detailed adjustments is required to understand the geographic patterns. Death rates are influenced not only by age, gender, race, and diabetic status, but by dialysis therapy, hematocrit level, membrane use, transplant rates, and modality change rates. The complexity of comparing hemodialysis and peritoneal dialysis, particularly over vary­ ing lengths of follow-up time, should also be considered. Reference population: the av­ erage 1997 incident patient of the same modality.

CHAPTER

8 · SURVIVAL,

MORTA

ITY,

& CAUSES

OF

DEATH

Hemodialysis, first-year death rates,1990-1992 combined

Hemodialysis,first-year death rates, 1993-1995 combined

Hemodialysis, second-year death rates, 1990-1992 combined

Hemodialysis, second-year death rates, 1993-1995 combined

Peritoneal dialysis,first-year death rates, 1990-1992 combined

Peritoneal dialysis, first-year death rates, 1993-1995 combined

Peritoneal dialysis, second-year death rates, 1990-1992 combined

Peritoneal dialysis, second-year death rates, 1993-1995 combined

Figure 8.20 Infectious death rates

per 100 patient years at risk, incident patients, by state, adjusted for age, gender, race, & diabetic status The distribution of infectious death rates parallels the pattern of insertion rates for cen­ tral venous catheters (fig 4.15). Rates of peritonitis and catheter complications should be investigated for their possible contribution to the geographic variation in infectious death rates, as should the effect of recently improved peritoneal dialysis delivery sys­ tems (which reduce the risk of contamination) and the differences between CAPD and CCPD. Reference population:the average 1997 incident patient of the same modality.

·

S137

Si38

·

2000

ATLAS

OF

ESRD

IN

THE

UNITED

STATES

Hemodialysis, first-year death rates,1990-1992 combined

Hemodialysis, first-year death rates, 1993-1995 combined

Hemodialysis, second-year death rates, 1990-1992 combined

Hemodialysis, second-year death rates, 1993-1995 combined

Peritoneal dialysis,first-year death rates, 1990-1992 combined

Peritoneal dialysis, first-year death rates, 1993-1995 combined

f

Peritoneal dialysis, second-year death rates, 1990-1992 combined

Peritoneal dialysis, second-year death rates, 1993-1995 combined

Figure 8.21 Cardiac death rates

per 100 patient years at risk, incident patients, by state, adjusted for age, gender, race, & diabetic status More detailed analyses of regional differences in cardiac death rates should evaluate the influences of comorbidity disease severity, transplantation rates, cardiovascular inter­ vention, and monitoring of diabetic patients for glycemic control and lipid disorders. Reference population:the average 1997 incident patient of the same modality.

CHAPTER

8

·

SURVIVAL,

Acute myocardial infarction Cardiac arrest, cause unknown Cardiac, other Atherosclerotic heart disease Cardiac arrhythmia Cardiomyopathy Pericarditis, including cardiac tamponade Pulmonary edema due to exogenous fluid Valvular heart disease Cerebrovascular (CVD, CVA/TIA) Cerebrovascular accident Ischemic brain damage Infection AIDS Fungal peritonitis Hepatitis B Infection, other Other viral hepatitis Pulmonary infection, bacterial Pulmonary infection, fungal Pulmonary infection, other

MORTALITY,

Septicemia, peritonitis Septicemia, PVD/gangrene Septicemia, vascular access Septicemia, other Tuberculosis Viral infection, CMV Viral infection, other Malignancy Malignant disease, history of immunosuppressive treatment Malignant disease, other Other known causes Accident related to treatment Accident unrelated to treatment Air embolism Bone marrow depression Cachexia Chronic obstr. pulmonary disease Cirrhosis Complications of surgery Dementia Diabetic coma, hypo/hyperglycemia Drug overdose

& CAUSES

OF

Drug overdose, street drugs Gl hemorrhage Hemorrhage, dialysis circuit Hemorrhage, ruptured vascular access Hemorrhage, surgery Hemorrhage, transplant site Hemorrhage, vascular access Hyperkalemia Liver failure, cause unknown Liver-drug toxicity Mesenteric infarction/ischemic bowel Other hemorrhage Other identified cause Pancreatitis Perforation of bowel Perforation of peptic ulcer Polycystic liver disease Pulmonary embolus Seizures Suicide Unknown Includes causes of death not recorded or no Death Notification form

DEATH

·

S139

Table 8.2 Cause of death categories

from HCFA Death Notification Form 2746

Figure 8.22 Cause-specific death rates by modality

prevalent diabetic patients aged 20 & older, i 996-i 998 combined, unadjusted

Hemodialysis Peritoneal dialysis Transplant

Myocardial infarction

Cardiac arrest

Cardiac other

CVD, CVA/TIA

Infection

Malignancy

Other known

Unknown

Figure 8.23 Cause-specific death rates by modality

prevalent non-diabetic patients aged 20 & older, 1996-1998 combined, unadjusted

70 -, Hemodialysis Peritoneal dialysis

Comparisons of prevalent death rates across modalities should be made with caution, as the rates may be influenced by patient time on ESRD, transplant rates, comorbiditydisease severity,dialysis therapy, and hematocrit level.

I Transplant ■

a

20

Myocardial infarction

Cardiac arrest

Cardiac other

CVD, CVA/TIA

Infection

Malignancy

Other known

Unknown

Si40

·

2000

ATLAS

OF

ESRD

IN

THE

UNITED

STATES

Figure 8.24 Cause-specific death rates by race prevalent male hemodialysis patients aged 20 & older, 1996} 998 combined, unadjusted

Other known

Unknown

Other known

Unknown

Other known

Unknown

Figure 8.25 Cause-specific death rates by race prevalent female hemodialysis panents aged 20 & older, 19961998 combined, unadjusted

Myocardia infarction

Figure 8.26 Cause-specific death rates by race prevalent male peritoneal dialysis panents aged 20 & older, 1996-1998 combined, unadjusted

CHAPTER

8

·

SURVIVAL,

MORTALITY,

& CAUSES

OF

DEATH

·

S141

Figure 8.27 Cause-specific death rates by race

60

prevalent female peritoneal dialysis patients aged 20 & older, 1996-1998 combined, unadjusted

White Black Native American Asian

Myocardial infarction

25

Cardiac arrest

Cardiac other

CVD, CVA/TIA

Infection

Malignancy

Other known

Unknown

Figure 8.28 Cause-specific death rates by race prevalent male transplant patients aged 20 & older, 19961998 combined, unadjusted

White Black

20

Native American Asian

Myocardial infarction

25

Cardiac arrest

Cardiac other

CVD, CVA/TIA

Infection

Malignancy

Other known

Unknown

Figure 8.29 Cause-specific death rates by race prevalent female transplant patients aged 20 & older, 19961998 combined, unadjusted

White Black Native American Asian

Myocardial infarction

Cardiac arrest

Cardiac other

CVD, CVA/TIA

nfection

Malignancy

Other known

Unknown

S i

4

2

·

2 0 0 0

A T L A S

OF

ESRD

IN

T H E

U N I T E D

S T A T E S

Figure 8.30 Cause-specific death rates by age group prevalent hemodialysis patients, 1996-1998 combined. unadjusted

Myocardial infarction

Malignancy

Other known

Unknown

Malignancy

Other known

Unknown

figure 8.31 Cause-specific death rates by age group prevalent peritoneal dialysis patients, 1996-1998 combined, unadjusted

Myocardial infarction

Figure 8.32 Cause-specific death rates by age group prevalent transplant patients, 1996-1998 combined, unadjusted 70 S 60

ΰ

Cardiac arrest

Cardiac other

CVD, CVA/TIA

Infection

0-19 20-44 45-64 65+

20 10 -

Myocardial infarction

Cardiac arrest

Cardiac other

CVD, CVA/TIA

Infection

Malignancy

Other known

Unknown